Upgrade existing LSR fortress instrument
Ended Awarded Last action
- Contract number
- HHSN26100037
- Awardee
-
Becton, Dickinson And Company UEI MM5ZHL8SRFY5 Part of Becton, Dickinson And Co
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,185
Award facts
- Contract value 100% obligated
- $5,185.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- Not on record
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$5,185 | |
| Original award | $10,370 |
About this award
The National Cancer Institute awarded a $5,185 firm fixed-price Blanket Purchase Agreement (BPA) call to Becton, Dickinson and Company (BD), operating through its BDB Division as BD Biosciences, for the upgrade of an existing LSR Fortress flow cytometry instrument. The contract, issued on July 31, 2015, with an ultimate completion date of August 31, 2015, was performed in Bethesda, Maryland and utilized no small business set-aside designation. This call represents a routine maintenance and upgrade activity under an existing BPA vehicle, leveraging BD's established capabilities in providing flow cytometry systems and associated technical support services to the National Institutes of Health.
BD Biosciences is a major supplier of advanced biomedical research technologies to federal agencies, with extensive experience providing flow cytometry instruments, reagents, and maintenance services. The company holds multiple significant Blanket Purchase Agreements and Indefinite Delivery Contracts with the Department of Veterans Affairs and NIH components, demonstrating its competitive position in the federal medical technology marketplace. The LSR Fortress upgrade represents a continuation of BD's long-standing relationship with the National Cancer Institute in supporting critical cancer research infrastructure and capabilities.
Quick answers
Who was awarded contract HHSN26100037?
HHSN26100037 was awarded to Becton, Dickinson And Company by National Cancer Institute (National Institutes of Health) on July 31, 2015.
How much is contract HHSN26100037 worth?
The government has obligated $5,185 on HHSN26100037.
Is contract HHSN26100037 an order under another contract?
Yes. HHSN26100037 is a BPA call under HHSN263200600063463B, a blanket purchase agreement.
Was contract HHSN26100037 competed?
The extent of competition for HHSN26100037 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award